BM Technologies Valuation
Is BMTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of BMTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: BMTX ($2.13) wird unter unserer Schätzung des Fair Value ($2.22) gehandelt.
Deutlich unter dem Marktwert: BMTX wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BMTX?
Other financial metrics that can be useful for relative valuation.
What is BMTX's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$19.11m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.09x |
Enterprise Value/EBITDA | -0.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BMTX's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 12x | ||
APCX AppTech Payments | 47.1x | n/a | US$23.5m |
XBP XBP Europe Holdings | 0.4x | n/a | US$61.2m |
RVYL Ryvyl | 0.2x | n/a | US$15.9m |
USIO Usio | 0.5x | 10.2% | US$39.9m |
BMTX BM Technologies | 0.3x | n/a | US$19.1m |
Price-To-Sales gegen Gleichaltrige: BMTX ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (0.4x) mit dem Durchschnitt der anderen Unternehmen (0.4x) vergleicht.
Price to Earnings Ratio vs Industry
How does BMTX's PE Ratio compare vs other companies in the US Diversified Financial Industry?
Price-To-Sales gegen Industrie: BMTX ist aufgrund seines Price-To-Sales Verhältnisses (0.6x) im Vergleich zum US Diversified Financial Branchendurchschnitt (2.4x) ein guter Wert.
Price to Sales Ratio vs Fair Ratio
What is BMTX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.3x |
Fair PS Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von BMTX für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | US$1.61 | US$6.42 +298.6% | 34.9% | US$8.00 | US$3.25 | n/a | 3 |
Mar ’25 | US$1.85 | US$6.75 +264.9% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Feb ’25 | US$2.13 | US$6.75 +217.6% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Jan ’25 | US$2.05 | US$6.75 +229.3% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Dec ’24 | US$3.16 | US$6.75 +113.6% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Nov ’24 | US$2.40 | US$6.75 +181.3% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Oct ’24 | US$2.00 | US$6.75 +237.5% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Sep ’24 | US$1.61 | US$6.75 +319.3% | 26.2% | US$8.00 | US$4.25 | n/a | 3 |
Aug ’24 | US$3.01 | US$7.67 +154.7% | 26.8% | US$10.00 | US$5.00 | n/a | 3 |
Jul ’24 | US$2.98 | US$9.33 +213.2% | 35.4% | US$13.00 | US$5.00 | n/a | 3 |
Jun ’24 | US$2.84 | US$9.33 +228.6% | 35.4% | US$13.00 | US$5.00 | n/a | 3 |
May ’24 | US$3.00 | US$9.67 +222.2% | 29.7% | US$13.00 | US$6.00 | n/a | 3 |
Apr ’24 | US$3.52 | US$9.67 +174.6% | 29.7% | US$13.00 | US$6.00 | US$1.57 | 3 |
Mar ’24 | US$3.35 | US$11.67 +248.3% | 29.1% | US$15.00 | US$7.00 | US$1.85 | 3 |
Feb ’24 | US$4.49 | US$14.33 +219.2% | 40.0% | US$21.00 | US$7.00 | US$2.13 | 3 |
Jan ’24 | US$5.21 | US$14.33 +175.1% | 40.0% | US$21.00 | US$7.00 | US$2.05 | 3 |
Dec ’23 | US$5.01 | US$14.33 +186.1% | 40.0% | US$21.00 | US$7.00 | US$3.16 | 3 |
Nov ’23 | US$7.53 | US$16.67 +121.3% | 28.7% | US$21.00 | US$10.00 | US$2.40 | 3 |
Oct ’23 | US$6.69 | US$16.67 +149.1% | 28.7% | US$21.00 | US$10.00 | US$2.00 | 3 |
Sep ’23 | US$6.26 | US$19.00 +203.5% | 31.0% | US$25.00 | US$11.00 | US$1.61 | 3 |
Aug ’23 | US$5.85 | US$19.33 +230.5% | 28.1% | US$25.00 | US$12.00 | US$3.01 | 3 |
Jul ’23 | US$5.89 | US$19.33 +228.2% | 28.1% | US$25.00 | US$12.00 | US$2.98 | 3 |
Jun ’23 | US$6.65 | US$19.33 +190.7% | 28.1% | US$25.00 | US$12.00 | US$2.84 | 3 |
May ’23 | US$7.60 | US$19.33 +154.4% | 28.1% | US$25.00 | US$12.00 | US$3.00 | 3 |
Apr ’23 | US$8.61 | US$22.00 +155.5% | 9.8% | US$25.00 | US$20.00 | US$3.52 | 3 |
Analysten-Prognose: Das Kursziel liegt um mehr als 20% über dem aktuellen Aktienkurs, aber die Analysten liegen nicht in einem statistisch sicheren Bereich der Übereinstimmung.